MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response

Overview of attention for article published in PLOS ONE, November 2012

Altmetric Badge

Mentioned by

twitter: 2 X users

patent: 9 patents

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

MHC class I associated peptides for prevention and treatment of zika virus

Grant US-11426457-B2

United States of America

Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell…

Grant US-11344614-B2

United States of America

Universal influenza vaccine compositions

Grant US-11273216-B2

United States of America

Antibodies to MICA and MICB proteins

Grant US-11066471-B2

United States of America

Antibodies to MICA and MICB proteins

Grant US-10851148-B2

United States of America

PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY

Application EP-3591047-A1

European Patent Office

MHC CLASS I ASSOCIATED PEPTIDES FOR PREVENTION AND TREATMENT OF MULTIPLE FLAVI VIRUS

Application WO-2019135086-A1

World Intellectual Property Organisation (WIPO)

MHC Class I Associated Peptides for Prevention and Treatment of Zika Virus

Application WO-2019058133-A3

World Intellectual Property Organisation (WIPO)

UNIVERSAL INFLUENZA VACCINE COMPOSITIONS

Application WO-2018127689-A1

World Intellectual Property Organisation (WIPO)